Navigation Links
NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Date:2/29/2008

BEDMINSTER, N.J., Feb. 29 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., executive vice president, chief operating officer, and chief executive officer-elect is scheduled to present at the Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami on Wednesday, March 19, 2008 at 3:15 p.m. ET. The presentation will be available as a live webcast with a replay available approximately 24 hours after the presentation has concluded. Interested parties may access the webcast from the NPS website, http://www.npsp.com.

About NPS Pharmaceuticals

NPS Pharmaceuticals is developing high value specialty therapeutics for gastrointestinal and endocrine disorders. The company is currently advancing two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS has also completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84 [rDNA origin] injection). NPS complements its internal programs with strategic partnerships, which include Amgen, GlaxoSmithKline, Kirin, and Nycomed. Additional information is available at http://www.npsp.com.


'/>"/>
SOURCE NPS Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
2. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
3. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
4. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
5. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
6. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
7. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
8. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
9. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
10. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
11. JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... UK (PRWEB) , ... September 21, 2017 , ... ... a QuintilesIMS company, who enable the world’s most progressive pharma and biotech organizations ... clinical trials at top pharma and biotech events in Q4. , DrugDev will ...
(Date:9/21/2017)... ... 21, 2017 , ... Biorez, Inc. , a regenerative ... Entrepreneur in Residence at Medtronic, Inc., to serve as an Independent Director on ... for anterior cruciate ligament (ACL) reconstruction that is designed to stabilize the knee ...
(Date:9/20/2017)... PA and College Station, TX (PRWEB) , ... ... ... IPS-Integrated Project Services, LLC (IPS), a leading global provider of engineering, ... Inc. the leading provider of prefabricated cleanrooms, today announced the unveiling of ...
(Date:9/20/2017)... ... September 20, 2017 , ... Foresight Institute, a leading think ... technologies, announced the winners for the 2017 Foresight Institute Feynman Prizes.These are given ... manufacturing. , Established in 1993 and named in honor of pioneer physicist Richard ...
Breaking Biology Technology:
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
Breaking Biology News(10 mins):